Capital International Sarl’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.8M | Buy |
128,286
+7,126
| +6% | +$2.32M | 0.8% | 30 |
|
|
2025
Q1 | $32.7M | Buy |
121,160
+6,018
| +5% | +$1.62M | 0.74% | 38 |
|
|
2024
Q4 | $27.1M | Sell |
115,142
-19,931
| -15% | -$4.69M | 0.63% | 44 |
|
|
2024
Q3 | $37.1M | Buy |
135,073
+25,258
| +23% | +$6.95M | 0.95% | 30 |
|
|
2024
Q2 | $26.7M | Buy |
109,815
+36,706
| +50% | +$8.92M | 0.81% | 33 |
|
|
2024
Q1 | $10.9M | Sell |
73,109
-14,248
| -16% | -$2.13M | 0.36% | 77 |
|
|
2023
Q4 | $16.7M | Buy |
87,357
+435
| +0.5% | +$83.3K | 0.63% | 54 |
|
|
2023
Q3 | $15.4M | Buy |
86,922
+2,523
| +3% | +$447K | 0.7% | 46 |
|
|
2023
Q2 | $16M | Buy |
84,399
+7,309
| +9% | +$1.39M | 0.72% | 44 |
|
|
2023
Q1 | $15.4M | Buy |
77,090
+10,214
| +15% | +$2.05M | 0.78% | 36 |
|
|
2022
Q4 | $15.9M | Buy |
66,876
+22,551
| +51% | +$5.36M | 1.12% | 15 |
|
|
2022
Q3 | $8.87M | Buy |
44,325
+13,456
| +44% | +$2.69M | 0.72% | 35 |
|
|
2022
Q2 | $4.5M | Buy |
30,869
+17,554
| +132% | +$2.56M | 0.36% | 93 |
|
|
2022
Q1 | $2.17M | Buy |
+13,315
| New | +$2.17M | 0.11% | 185 |
|